Delivery Order SPE2DR25D9239-SPE2DR26FFCH8
Award Date 3/10/26
Potential Completion Date 3/11/26
Potential Value $114K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, for JAKAFI 5 mg tablets (60-count units) with a ceiling value of $25,441.84 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with place of performance in Park Ridge, IL 60068 and an ultimate completion date of March 10, 2026. The PPV-G GEN V...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, with a ceiling value of $25,326.56 for supply of JAKAFI 10 mg tablets (60 count), with ultimate completion by March 2, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceuticals and medical consumables to support military...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, with a ceiling value of $12,663.27 for JAKAFI 10 mg tablets (60-count units), ultimate completion by March 10, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $25,326.56 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order has a firm fixed-price structure with an ultimate completion date of March 3, 2026. The PPV-G GEN V is a Defense Logistics Agency...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $18,516.41 for supply of JAKAFI 5 mg tablets (60 count) under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of February 10, 2026. PPV-G GEN V...
- The Defense Logistics Agency issued a $12,603.07 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, for JAKAFI 25 mg tablets (60-count unit). The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations...
- The Defense Logistics Agency issued a $12,663.27 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance...
- The Defense Logistics Agency issued a $12,663.27 delivery order to DMS Pharmaceutical Group Inc. on March 4, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler....
- <p>The Defense Logistics Agency issued a $72,615.58 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group is a woman-owned small business. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 3, 2026. The order is priced firm fixed price with no set-aside designation.</p>
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for JAKAFI 10 mg tablets (60-count units) with a ceiling value of $37,989.81 and an ultimate completion date of March 6, 2026. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion vehicle established to supply...